AI-powered blood test detects Parkinson's disease years before symptoms appear, revolutionizing early diagnosis and treatment strategies.

Sleep problems are very common in people with Parkinson’s disease and are associated with poorer quality of life in patients, according to a new Irish study.

Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics models to Parkinson's disease. Researchers identified genetic factors in progression and FDA-approved drugs that can potentially be repurposed for PD treatment.

Inhibikase Therapeutics said on Wednesday it would stop development of its experimental Parkinson's disease drug after it failed to improve patients' ability to carry out daily tasks such as eating and walking in a mid-stage study.

A Colorado Springs family hopes to win what they believe would be a landmark legal verdict by proving to jurors next month that mold exposure in a rented apartment caused Parkinson’s disease in a former head of several Olympic sports organizations.

Mark Giaquinto was diagnosed with Parkinson's disease five years ago and continues to combat the illness with a positive outlook.

At Rock Steady Boxing West Michigan, patients are using boxing as a form of therapy to combat the effects of Parkinson's.

A new EPA ban on TCE, a common industrial cleaning agent and contaminant, begins this year. UCSF’s Samuel Goldman, who led groundbreaking research to link TCE to Parkinson’s Disease, talks about the health risks.

In a significant advancement for Parkinson’s Disease (PD) therapy, researchers have developed a targeted nano formulation capable of providing sustained release of 17β-Estradiol (E2), a hormone crucial for managing neurodegenerative conditions like PD.

Patients living with Parkinson’s disease are encouraged to engage in regular exercise to help manage symptoms and improve their overall well-being.

Inhibikase Therapeutics announced disappointing results from a Phase 2 trial for its Parkinson’s disease drug, risvodetinib, and will now pause its development.

In the end, I have to be my best advocate for my own care. It took years, but when I became my best advocate, serious change happened,” Choi says.